Predatory Pricing Charge Punishes Valeant Pharmaceuticals Intl Inc (VRX)

Valeant Pharmaceuticals Intl Inc (VRX) is again being accused of overcharging for drugs

Mar 28, 2016 at 1:34 PM
facebook X logo linkedin


Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is diving on the latest accusations of predatory pricing. This time around, investors in Sprout have accused the drugmaker of failing to successfully commercialize the female libido pill by charging two times what market research determined would be an appropriate price. As such, VRX is down 7.8%, which should come as a welcome development for at least one group of options bears.

One of the most active VRX strikes during the past two weeks has been the May 27.50 put, where roughly 27,500 contracts have been added to open interest. Based on data from the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), the majority of these positions have been bought to open, suggesting the traders expect even more downside by back-month expiration, at the close on Friday, May 20. However, even if VRX remains above the strike throughout the option's lifetime, these buyers risk forfeiting no more than the initial premium paid.

While a number of short-term traders have been targeting calls, VRX's Schaeffer's put/call open interest ratio (SOIR) of 1.14 reveals a prevailing bias toward puts, on an absolute basis. For comparison's sake, two weeks ago, the SOIR was 1.01, with put and call open interest roughly even among options with a shelf-life of three months or less.

The interest in puts makes sense in light of Valeant Pharmaceuticals Intl Inc's (NYSE:VRX) long-term technical struggles. The stock settled 2015 in triple-digit territory, but is now hovering around $28.66. Last week, in fact, VRX hit a five-year low of $25.99.

Sign up now for Schaeffer's Market Recap to get all the day's big stock movers, must-know technical levels, and top economic stories straight to your inbox.

 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI